MYI PHARMA LTD - Accounts

MYI PHARMA LTD
Statement of Financial Position
As at 30 April 2025

	2025		2024
	£	£	£	£
Fixed assets		840		1,120
Current assets	12,395		7,678
Creditors: amount falling due within one year	(12,042)		(7,894)
Net current assets		353		(216)
Total assets less current liabilities		1,193		904
Net assets		1,193		904


Capital and reserves		1,193		904

NOTES TO THE ACCOUNTS

General Information

MYI PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 14782800, registration address 38 BIGNOR STREET, MANCHESTER ENGLAND, M8 0SE.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

2.	Average number of employees Average number of employees during the year was 1 (2024 : 1).

For the year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.

The financial statements were approved by the director on 29 April 2026 and were signed by:

--------------------------------
Mohammed Ibrahim REHMAN
Director

Registered Number: 14782800
England and Wales
MYI PHARMA LTD

Abridged Accounts

Period of accounts Start date: 01 May 2024 End date: 30 April 2025